参考文献/References:
[1]左媛媛,郭宏宇,郭文秀,等.呼和浩特市体检人群甲状腺疾病患病情况及其危险因素研究[J].中华地方病学杂志,2020,39(7):477-482.[2]杨慧慧,高欣彤,窦元元,等.甲状腺功能正常人群血清促甲状腺激素水平与血脂水平的关系分析[J].贵州医药,2021,45(6):889-890.[3]李蕊娟,李景丽,刘双双.2型糖尿病患者甲状腺体积与代谢相关指标关系研究[J].华南预防医学,2021,47(5):664-666.[4]曹丹凤,熊慧峰.围绝经期综合征患者甲状腺激素性腺激素及糖脂代谢指标水平与骨密度的相关性[J].中国妇幼保健,2021,36(19):4595-4598.[5]姜晓洪.中老年2型糖尿病合并甲状腺功能异常患者的临床特点分析[J].保健医学研究与实践,2021,18(3):65-68.[6]林克莉,赵纪波.甲亢合并糖尿病患者的血糖/血脂变化的临床探究[J].中国农村卫生,2021,13(12):40-41.[7]刘宝英,梁干雄,叶凯云.糖尿病合并甲状腺功能亢进症患者临床特点分析[J].黑龙江医药,2021,34(3):673-675.[8]李欣颖,曾敏,郑茵,等.甲亢患者的胰岛功能变化及与胰岛素抵抗的相关性分析[J].中国热带医学,2019,19(6):563-565.[9]曹余,朱文林,储午阳.T2DM患者糖脂代谢、甲状腺激素和抗体水平变化及临床意义[J].中国医药导报,2021,18(24):68-71.[10]郭新红,张青春,孔艳华,等.2型糖尿病甲状腺功能正常病人甲状腺激素与代谢指标的相关性分析[J].蚌埠医学院学报,2021,46(8):1041-1044.[11]沙益锋,沈莉敏,陈晓丽,等.Graves病甲亢患者血清甲状腺激素水平与血脂水平的相关性[J].西部医学,2016,28(2):218-220.[12]Selim FO,Ahmed AAM.The association between serum paraoxonase-1 activity, thyroid hormones and lipids profile in patients with primary hyperthyroidism[J].International Journal of Advanced Research, 2014,2(11):172-181.[13]肖林,郭梅,范瑞云.甲状腺激素水平与甲状腺功能亢进患者血脂代谢关系研究[J].中国实验诊断学,2016,20(10):1679-1681.[14]马海丽,胡艳红,李万森.甲亢患者血清促甲状腺激素水平与甲状腺激素及血糖、血脂代谢水平的相关性[J].中国实用医刊,2020(2):91-93.[15]Piantanida E,Gallo D,Veronesi G,et al.Masked hypertension in newly diagnosed hypothyroidism: a pilot study[J].Journal of Endocrinological Investigation,2016,39(10):1131-1138.[16]王雪琴,王伟.亚临床甲减对糖尿病患者血糖、血脂、尿酸水平的影响[J].解放军预防医学杂志,2019,37(5):47-48.[17]王玫,任安.805例住院2型糖尿病患者甲状腺功能的回顾性分析[J].临床与病理杂志,2014,34(5):525-529.[18]Ding XY,Xu Y,Wang YF,et al.Gender disparity in the relationship between prevalence of thyroid nodules and metabolic syndrome compo-nents: the SHDC- CDPC community - based study[J].Mediators In-flam,2017,21(1):1-11.[19]赵玲玲.甲状腺功能减退对妊娠期糖尿病孕妇糖代谢及胰岛素敏感性的影响[J].中国妇幼保健,2020,35(4):634-636.[20]Turcios S,Lence-Anta JJ,Santana JL,et al.Thyroid Volume and Its Relation to Anthropometric Measures in a Healthy Cuban Population[J].European Thyroid Journal,2015,4(1):55-61.[21]洪燕青,邸阜生.TSH、血脂水平及肾功能、甲状腺功能与2型糖尿病患者肾损伤的相关性[J].贵州医科大学学报,2021,46(3):362-366.[22]Hee LM,Uee LJ,Hye JK,et al.Thyroid dysfunction associated with follicular cell steatosis in obese male mice and humans[J].Endocrinology,2015(3):1181-1193.[23]叶文春,方向明,王玉容,等.亚临床甲状腺功能减退症患者促甲状腺素水平与血脂的关系研究[J].华西医学,2015,30(5):846-849.[24]孙琴.2型糖尿病合并亚临床甲状腺功能减退患者血脂及甲状腺特异性抗体水平分析[J].检验医学与临床,2019,16(13):1813-1815.[25]王宏亮,刘亚明.亚临床甲状腺功能异常患者甲功五项水平与血脂的变化[J].贵州医药,2017,41(6):590-592.[26]李素燕,陈倩雅.代谢综合征患者血脂水平与甲状腺功能相关性探讨[J].深圳中西医结合杂志,2016,26(24):85-86.[27]Piantanida E,Gallo D,Veronesi G,et al.Masked hypertension in newly diagnosed hypothyroidism: a pilot study[J].Journal of Endocrinological Investigation,2016,39(10):1131-1138.[28]孙彦琴,贾永平,吕吉元,等.亚临床甲状腺功能减退对原发性高血压病人血压变异性的影响[J].中西医结合心脑血管病杂志,2021,19(18):3184-3188.[29]韩菲,张媛媛.甲状腺功能减退症患者动脉粥样硬化的相关影响因素分析[J].中华老年心脑血管病杂志,2019,21(6):626-628.[30]顾朋颖,叶山东,康冬梅,等.甲状腺功能正常的中老年男性高血压患者促甲状腺激素水平与肥胖相关性[J].安徽医科大学学报,2016,51(3):453-456.[31]邵芝娟,时立新,徐淑静,等.血清促甲状腺激素与肥胖的相关性[J].广东医学,2016,37(3):432-435.[32]Iwen KA,Schroder E,Brabant G.Thyroid Hormones and the Metabolic Syndrome[J].European Thyroid Journal, 2013,2(2):83-92.[33]段晓梅,郝立月,李丽婷,等.高脂膳食诱导的甲状腺激素改变对肥胖易感性的影响[J].营养学报,2016,38(1):41-47.[34]杨芳,张亚琴,陈明卫,等.合肥市社区常住居民糖代谢异常人群中甲状腺结节患病特点及影响因素的分析[J].安徽医科大学学报,2018,53(7):1121-1125.[35]贾晓炜,贾贺堂.糖代谢异常与甲状腺体积增大和甲状腺结节患病率的相关性[J].华南国防医学杂志,2015,29(5):356-359.[36]王博,刘珺,张玄娥,等.糖代谢异常与甲状腺结节相关性研究[J].中国全科医学,2015,18(30):3648-3652.[37]庞雅平,申晶,贾贺堂.甲状腺恶性结节相关危险因素分析[J].解放军医药杂志,2015,27(7):67-69.[38]常星宇,傅松波,汤旭磊,等.脂代谢异常人群甲状腺结节检出情况及相关因素分析[J].中华地方病学杂志,2021,40(9):718-723.[39]莎仁高娃,王振捷,苏绍荣,等.体检人群甲状腺结节与身高、体重及体质指数的相关性研究[J].标记免疫分析与临床,2018,25(5):598-601.
相似文献/References:
[1]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(04):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[2]龙 颖,李运泽,汤中敏,等.非酒精性脂肪性肝病与血尿酸水平测定及其临床意义[J].医学信息,2018,31(07):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
LONG Ying,LI Yun-ze,TANG Zhong-min,et al.Determination of Serum Uric Acid Level and its Clinical Significance in Non-alcoholic Fatty Liver Disease[J].Medical Information,2018,31(04):92.[doi:10.3969/j.issn.1006-1959.2018.07.029]
[3]吕 宁,徐 昕,黄 永,等.公安民警皮肤软纤维瘤与代谢综合征危险因素相关性研究[J].医学信息,2018,31(10):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
LV Ning,XU Xin,HUANG Yong,et al.Correlative Study on Skin Soft Fibroma and Risk Factors of Metabolic Syndrome in Public Security Police[J].Medical Information,2018,31(04):69.[doi:10.3969/j.issn.1006-1959.2018.10.021]
[4]薛 瑶,高 妮,高 逍,等.榆林市职业人群代谢综合征的患病情况及影响因素[J].医学信息,2022,35(13):7.[doi:10.3969/j.issn.1006-1959.2022.13.002]
XUE Yao,GAO Ni,GAO Xiao,et al.Prevalence and Influencing Factors of Metabolic Syndrome Among Occupational Population in Yulin[J].Medical Information,2022,35(04):7.[doi:10.3969/j.issn.1006-1959.2022.13.002]
[5]王本泉,项本宏,邱 钧.胰岛素抵抗与甲状腺结节的关系研究进展[J].医学信息,2022,35(14):154.[doi:10.3969/j.issn.1006-1959.2022.14.040]
WANG Ben-quan,XIANG Ben-hong,QIU Jun.Research Progress on the Relationship Between Insulin Resistance and Thyroid Nodules[J].Medical Information,2022,35(04):154.[doi:10.3969/j.issn.1006-1959.2022.14.040]
[6]刘柏基,熊波波.代谢综合征与良性前列腺增生合并下尿路症状的关系
及治疗研究[J].医学信息,2019,32(17):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
LIU Bai-ji,XIONG Bo-bo.Relationship between Metabolic Syndrome and Benign Prostatic Hyperplasia with
Lower Urinary Tract Symptoms and Treatment[J].Medical Information,2019,32(04):28.[doi:10.3969/j.issn.1006-1959.2019.17.010]
[7]符春辉,廖金平,李秋实.老年2型糖尿病患者血清GGT、RBP4水平与代谢综合征发生的相关性研究[J].医学信息,2022,35(15):83.[doi:10.3969/j.issn.1006-1959.2022.15.018]
FU Chun-hui,LIAO Jin-ping,LI Qiu-shi.Correlation Between Serum GGT, RBP4 Levels and Metabolic Syndrome in Elderly Patients with Type 2 Diabetes Mellitus[J].Medical Information,2022,35(04):83.[doi:10.3969/j.issn.1006-1959.2022.15.018]
[8]李淑娟,王爱芹,杨学军,等.异常子宫出血患者子宫内膜病理类型与
临床特征的关系[J].医学信息,2019,32(14):104.[doi:10.3969/j.issn.1006-1959.2019.14.032]
LI Shu-juan,WANG Ai-qin,YANG Xue-jun,et al.Relationship between Pathologic Type of Endometrium and Its Clinical Features in
Patients with Abnormal Uterus Bleeding[J].Medical Information,2019,32(04):104.[doi:10.3969/j.issn.1006-1959.2019.14.032]
[9]谢春燕.化学发光免疫分析法在甲状腺疾病诊断中的应用[J].医学信息,2019,32(16):169.[doi:10.3969/j.issn.1006-1959.2019.16.058]
XIE Chun-yan.Application of Chemiluminescence Immunoassay in the Diagnosis of Thyroid Diseases[J].Medical Information,2019,32(04):169.[doi:10.3969/j.issn.1006-1959.2019.16.058]
[10]王 剑,李凤英.2型糖尿病患者血尿酸水平与代谢综合征的相关性分析[J].医学信息,2020,33(08):123.[doi:10.3969/j.issn.1006-1959.2020.08.039]
WANG Jian,LI Feng-ying.Relationship Between Blood Uric Acid Level and Metabolic Syndrome in Type 2 Diabetes[J].Medical Information,2020,33(04):123.[doi:10.3969/j.issn.1006-1959.2020.08.039]